Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue

A. Sano, A. Suzuki, Hiromitsu Ohmori, M. Kikuchi

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

The aim of the high-dose methotrexate (MTX) chemotherapy followed by rescue by infusion of leucovorin (LV) is to enhance the effects of the MTX on luekemic cells without increasing its toxicity to normal leukocyte cells. Physiological aspects of the high-dose MTX therapy combined with the rescue agent LV are investigated via the modelling and control systems approach to attain careful administration of MTX and LV. A compartmental model is given to describe the pharmacokinetics of administered MTX and LV, the cell kinetics of normal and leukemic cells and the cell-kill and cell-rescue effects. Based on this model, the optimal control scheme for infusing the rescue agent LV is given in a closed-loop form using the monitored cell number of normal leukocyte so as to rescue the normal cells selectively from MTX toxicity. The optimal continuous therapy of MTX is also discussed on a standpoint of closed-loop control, which can be implemented by monitoring the leukemic cell number in blood.

Original languageEnglish
Title of host publicationIFAC Symposia Series - Proceedings of a Triennial World Congress
EditorsU. Jaaksoo, V.I. Utkin
PublisherPubl by Pergamon Press Inc
Pages237-242
Number of pages6
Volume2
Publication statusPublished - 1991
EventProceedings of the 11th Triennial World Congress of the International Federation of Automatic Control - Tallinn, USSR
Duration: 1990 Aug 131990 Aug 17

Other

OtherProceedings of the 11th Triennial World Congress of the International Federation of Automatic Control
CityTallinn, USSR
Period90/8/1390/8/17

Fingerprint

Toxicity
Pharmacokinetics
Chemotherapy
Blood
Control systems
Kinetics
Monitoring

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Sano, A., Suzuki, A., Ohmori, H., & Kikuchi, M. (1991). Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue. In U. Jaaksoo, & V. I. Utkin (Eds.), IFAC Symposia Series - Proceedings of a Triennial World Congress (Vol. 2, pp. 237-242). Publ by Pergamon Press Inc.

Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue. / Sano, A.; Suzuki, A.; Ohmori, Hiromitsu; Kikuchi, M.

IFAC Symposia Series - Proceedings of a Triennial World Congress. ed. / U. Jaaksoo; V.I. Utkin. Vol. 2 Publ by Pergamon Press Inc, 1991. p. 237-242.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Sano, A, Suzuki, A, Ohmori, H & Kikuchi, M 1991, Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue. in U Jaaksoo & VI Utkin (eds), IFAC Symposia Series - Proceedings of a Triennial World Congress. vol. 2, Publ by Pergamon Press Inc, pp. 237-242, Proceedings of the 11th Triennial World Congress of the International Federation of Automatic Control, Tallinn, USSR, 90/8/13.
Sano A, Suzuki A, Ohmori H, Kikuchi M. Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue. In Jaaksoo U, Utkin VI, editors, IFAC Symposia Series - Proceedings of a Triennial World Congress. Vol. 2. Publ by Pergamon Press Inc. 1991. p. 237-242
Sano, A. ; Suzuki, A. ; Ohmori, Hiromitsu ; Kikuchi, M. / Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue. IFAC Symposia Series - Proceedings of a Triennial World Congress. editor / U. Jaaksoo ; V.I. Utkin. Vol. 2 Publ by Pergamon Press Inc, 1991. pp. 237-242
@inproceedings{cccc5c0db00a4e759fcf69ff8e2be3b1,
title = "Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue",
abstract = "The aim of the high-dose methotrexate (MTX) chemotherapy followed by rescue by infusion of leucovorin (LV) is to enhance the effects of the MTX on luekemic cells without increasing its toxicity to normal leukocyte cells. Physiological aspects of the high-dose MTX therapy combined with the rescue agent LV are investigated via the modelling and control systems approach to attain careful administration of MTX and LV. A compartmental model is given to describe the pharmacokinetics of administered MTX and LV, the cell kinetics of normal and leukemic cells and the cell-kill and cell-rescue effects. Based on this model, the optimal control scheme for infusing the rescue agent LV is given in a closed-loop form using the monitored cell number of normal leukocyte so as to rescue the normal cells selectively from MTX toxicity. The optimal continuous therapy of MTX is also discussed on a standpoint of closed-loop control, which can be implemented by monitoring the leukemic cell number in blood.",
author = "A. Sano and A. Suzuki and Hiromitsu Ohmori and M. Kikuchi",
year = "1991",
language = "English",
volume = "2",
pages = "237--242",
editor = "U. Jaaksoo and V.I. Utkin",
booktitle = "IFAC Symposia Series - Proceedings of a Triennial World Congress",
publisher = "Publ by Pergamon Press Inc",

}

TY - GEN

T1 - Model based optimal control scheme for high-dose methotrexate ch motherapy followed by leucovorin rescue

AU - Sano, A.

AU - Suzuki, A.

AU - Ohmori, Hiromitsu

AU - Kikuchi, M.

PY - 1991

Y1 - 1991

N2 - The aim of the high-dose methotrexate (MTX) chemotherapy followed by rescue by infusion of leucovorin (LV) is to enhance the effects of the MTX on luekemic cells without increasing its toxicity to normal leukocyte cells. Physiological aspects of the high-dose MTX therapy combined with the rescue agent LV are investigated via the modelling and control systems approach to attain careful administration of MTX and LV. A compartmental model is given to describe the pharmacokinetics of administered MTX and LV, the cell kinetics of normal and leukemic cells and the cell-kill and cell-rescue effects. Based on this model, the optimal control scheme for infusing the rescue agent LV is given in a closed-loop form using the monitored cell number of normal leukocyte so as to rescue the normal cells selectively from MTX toxicity. The optimal continuous therapy of MTX is also discussed on a standpoint of closed-loop control, which can be implemented by monitoring the leukemic cell number in blood.

AB - The aim of the high-dose methotrexate (MTX) chemotherapy followed by rescue by infusion of leucovorin (LV) is to enhance the effects of the MTX on luekemic cells without increasing its toxicity to normal leukocyte cells. Physiological aspects of the high-dose MTX therapy combined with the rescue agent LV are investigated via the modelling and control systems approach to attain careful administration of MTX and LV. A compartmental model is given to describe the pharmacokinetics of administered MTX and LV, the cell kinetics of normal and leukemic cells and the cell-kill and cell-rescue effects. Based on this model, the optimal control scheme for infusing the rescue agent LV is given in a closed-loop form using the monitored cell number of normal leukocyte so as to rescue the normal cells selectively from MTX toxicity. The optimal continuous therapy of MTX is also discussed on a standpoint of closed-loop control, which can be implemented by monitoring the leukemic cell number in blood.

UR - http://www.scopus.com/inward/record.url?scp=0025844622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025844622&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:0025844622

VL - 2

SP - 237

EP - 242

BT - IFAC Symposia Series - Proceedings of a Triennial World Congress

A2 - Jaaksoo, U.

A2 - Utkin, V.I.

PB - Publ by Pergamon Press Inc

ER -